Phishing warning 01-May-2024
We are aware of phishing emails targeting speakers of events whose names appear on our events pages. If you are unsure if an email regarding event registration or accommodation has come from us please contact us and do not provide any credit card details or personal information

2nd SCI / RSC Symposium on Antimicrobial Drug Discovery

12 November 2018 12:00 - 13 November 2018 16:45, London , United Kingdom

Monday 12 - Tuesday 13 November 2018, SCI, London, UK
Monday 12 November
  • 12:00 Registration, exhibition and lunch
  • 13:00 Opening remarks
  • 13:10 Antibiotics: challenges and opportunities - Dr Stephen Baker, GlaxoSmithKline
  • 13:55 Rational and irrational discovery of novel interventions to treat drug-resistant infections - Prof Matt Cooper, University of Queensland and Inflazome
  • 14:40 Flash poster presentations
  • 15:00 Refreshment break and exhibition
  • 15.30 Towards photopharmacological antimicrobial chemotherapy - Dr Matthew Fuchter, Imperial College London
  • 16:00 SPARKing new antibiotic discovery - Wes King, The Pew Charitable Trusts
  • 16.30 Research and development of new antimicrobial drugs and combinations: a not-for-profit approach - Prof Laura Piddock, Global Antibiotic Research & Development Partnership
  • 17:15 Networking and refreshments

Tuesday 13 November
  • 09:00 Rules for bacterial penetration - what we know and what we don't - Dr Paul Finn, Oxford Drug Design
  • 09:30 Reversing efflux-mediated resistance to reinvent broad-spectrum antibiotics  -Dr K Miraz Rahman, King’s College London
  • 10:00 Predictive guidelines for compound accumulation lead to new broad-spectrum antibiotics - Prof Paul Hergenrother, University of Illinois
  • 10:45 Refreshment break and exhibition
  • 11:15 Non-hydroxamate LpxC inhibitors - Dr Alastair Parkes, Evotec
  • 11:45 Novel immunotherapeutics to target Gram-negative bacterial infections - Dr Emma Leire, Centauri Therapeutics
  • 12:15 Analysis of poatassium (K+) efflux systems (Kef) as an antibiotic target n pathogenic bacteria - Catherine Haslam, University of Oxford
  • 12:30 Turning strength in to weakness: exploiting resistance as a novel therapeutic target - Lindsay Evans, Imperial College, London
  • 12.45 MAPS: Multiparameter Assay for Profiling Susceptibiity - Dr Lisa Miller, University of York
  • 13:00 Lunch and exhibition
  • 14:00 Short antimicrobial peptides - their potential against multidrug-resistant bacteria - Dr Kai Hilpert, St George’s, University of London
  • 14:30 From HTS to preclinical candidate: a novel small-molecule antibiotic for the treatment of drug-resistant Neisseria gonorrhoeae - Dr Paul Meo, Summit Therapeutics
  • 15:00 Refreshment break and exhibition
  • 15:30 Metallo β-lactamase inhibitors: an approach to combat the threat of emerging carbapenem resistance due to metallo β-lactamase enzymes in Gram-negative bacteria - Dr David Davies, AntaBio
  • 16:00 Challenges in antibacterial drug discovery - Prof Ian Gilbert, University of Dundee
  • 16:45 Closing remarks
Call for Poster Abstracts
Anyone wishing to present a poster should submit a one-page abstract to by Fri 14 September 2018 with "AMR-poster abstract" in the subject line.  Selected poster presenters will be given the opportunity to give a flash presentation.
A limited number of bursaries are available to SCI/RSC student members to cover their registratation fees and contribute to their travel and accomodation costs.  To apply for a bursary, please send an email to by Fri 14 September 2018 with "AMR II - burrsary application" in the subject line.
Exhibition and Sponsorship
An exhiition will take place alongside the conference. Companies and related organisations who may wish to exhibit, please email for further information and prices.  Spaces are limited and will be allocated on a first-come first-served basis


SCI, 14/15 Belgrave Square, London , SW1X 8PS, United Kingdom

Organised by
Organising Committee
  • Dr Liam Cox, SCI / University of Birmingham
  • Dr Caroline Low, SCI / Computational Medicinal Chemistry Consultant
  • Dr Sarah Major, SCI / Evotec (UK) Ltd
  • Dr Pascal Savy, SCI / Charles River Laboratories
  • Dr Francis Wilson, RSC / Summit Therapeutics
Contact information
Showing all upcoming events
Start Date
End Date
Subject area
Event type


E-mail Enquiry